MorphoSys AG (MOR): Price and Financial Metrics
MOR Price/Volume Stats
| Current price | $18.96 | 52-week high | $19.50 |
| Prev. close | $18.51 | 52-week low | $4.18 |
| Day low | $18.38 | Volume | 19,100 |
| Day high | $19.15 | Avg. volume | 1,019,393 |
| 50-day MA | $18.41 | Dividend yield | N/A |
| 200-day MA | $14.43 | Market Cap | 2.86B |
MOR Stock Price Chart Interactive Chart >
MorphoSys AG (MOR) Company Bio
MorphoSys AG engages in the research, development, and optimization of therapeutic antibody drug candidates in partnership with pharmaceutical and biotechnology companies. The company, together with its pharmaceutical partners, develops a therapeutic pipeline of approximately 100 drugs for the treatment of cancer, Alzheimer's disease, infectious diseases, cardiovascular dysfunction, and inflammation. The company was founded in 1992 and is based in Planegg, Germany.
MOR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 2.27% |
| 1-year | 316.70% |
| 3-year | 95.67% |
| 5-year | -34.03% |
| YTD | 91.52% |
| 2023 | 176.54% |
| 2022 | -62.00% |
| 2021 | -66.76% |
| 2020 | -20.55% |
| 2019 | 40.99% |
Continue Researching MOR
Here are a few links from around the web to help you further your research on MorphoSys AG's stock as an investment opportunity:MorphoSys AG (MOR) Stock Price | Nasdaq
MorphoSys AG (MOR) Stock Quote, History and News - Yahoo Finance
MorphoSys AG (MOR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...